Abstract
Background
Somatoform disorders are an important factor in functional disability and role impairment, though their independent contribution to disability has been unclear because of prevalent medical and psychiatric comorbidity.
Objectives
To assess the extent of the overlap of somatization with other psychiatric disorders and medical problems, to compare the functional disability and role impairment of somatizing and non-somatizing patients, and to determine the independent contribution of somatization to functional disability and role impairment.
Design
Patients were surveyed with self-report questionnaires assessing somatization, psychiatric disorder, and role impairment. Medical morbidity was indexed with a computerized medical record audit.
Participants
Consecutive adults making scheduled visits to their primary care physicians at two hospital-affiliated primary care practices on randomly chosen days.
Measurements
Intermediate activities of daily living, social activities, and occupational disability.
Results
Patients with somatization, as well as those with serious medical and psychiatric illnesses, had significantly more impairment of activities of daily life and social activities. When these predictors were considered simultaneously in a multivariable regression, the association with somatization remained highly significant and was comparable to or greater than many major medical conditions.
Conclusions
Patients with somatization had substantially greater functional disability and role impairment than non-somatizing patients. The degree of disability was equal to or greater than that associated with many major, chronic medical disorders. Adjusting the results for psychiatric and medical co-morbidity had little effect on these findings.
Similar content being viewed by others
References
Berardi D, Ceroni GB, Leggieri G, Rucci P, Ustun B, Ferrari G. Mental, physical, and functional status in primary care attenders. Int J Psychiat Med. 1999;29:133–48.
Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job performance deficits due to depression. Am J Psychiat. 2006;163:1569–76.
Eisner MD, Yelin EH, Trupin L, Blanc PD. The influence of chronic respiratory conditions on health status and work disability. Am J Pub Health. 2002;92:1506–13.
American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–32.
Smith GR, Monson RA, Ray DC. Patients with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Arch Intern Med. 1986;146:69–72.
Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: a spectrum of severity. Am J Psychiat. 1991;148:34–40.
Gureje O, Simon GE, Ustun TB, Goldberg DP. Somatization in cross-cultural perspective: a world health organization study in primary care. Am J Psychiat. 1997;154:989–95.
Swartz M, Landerman R, George L, et al. Somatization disorder. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America. New York: Free Press; 1991:220–57.
Escobar JI, Golding JM, Hough RL, Karno M, Burnham MA, Wells KB. Somatization in the community: relationship to disability and use of services. Am J Pub Health. 1987;77:837–40.
Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol Med. 1997;27:1011–9.
Kroenke K, Spitzer RL, Williams JBW, Linzer M, Hahn SR, deGruy FV, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774–9.
Creed F. Should general psychiatry ignore somatization and hypochondriasis? World Psychiatry. 2006;5:146–50.
Looper KJ, Kirmayer LJ. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol. 2002;70:810–27.
Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: A review of the literature. Psychosom Med. 2002;64:939–50.
Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–15.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258–66.
Interian A, Allen LA, Gara MA, Escobar JI, Diaz-Martinez AM. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics. 2006;47:392–8.
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD. JAMA. 1999;282:1737–44.
Jette AM, Davies AR, Cleary PD, Calkins DR, Rubenstein LV, Fink A, et al. The Functional Status Questionnaire: reliability and validity when used in primary care. J Gen Int Med. 1986;1:143–9.
Barsky AJ, Orav JE, Ahern DK, Rogers MP, Gruen SD, Liang MH. Somatic style and symptom reporting in rheumatoid arthritis. Psychosomatics. 1999;40:396–403.
Barsky AJ, Fama JM, Bailey ED, Ahern DK. A prospective 4–5 year study of DSM-III-R hypochondriasis. Arch Gen Psychiat. 1998;55:737–44.
Barsky AJ, Cleary PD, Coeytaux RR, Ruskin JN. The clinical course of palpitations in medical outpatients. Arch Intern Med. 1995;155:1782–8.
Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiat. 2005;62:903–10.
Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.
Charlson ME, Szatrowski TP, Perterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.
Servaes P, Prins J, Verhagen S, Bleijenberg G. Fatigue after breast cancer and in chronic fatigue syndrome. Similarities and differences. J Psychosom Res. 2002;52:453–9.
Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med. 1995;25:1259–67.
Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnosis and functional disability. Psychosom Med. 1997;59:565–71.
Sullivan M, Clark MR, Katon WJ, Fischl M, Russo J, Dobie RA. Psychiatric and otologic diagnoses in patients complaining of dizziness. Arch Intern Med. 1993;153:1479–84.
Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Int Med. 2007;20:1032–7.
Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86:262–6.
Potts SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study. Psychol Med. 1995;25:339–47.
Smith RC, Lyles JS, Gardiner JC, Sirbu C, Hodges A, Collins C, et al. Primary care clinicians treat patients with medically unexplained symptoms - A randomized controlled trial. J Gen Int Med. 2006;21:671–7.
Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis; A randomized controlled trial. JAMA. 2004;291:1464–70.
Acknowledgements
We wish to acknowledge the invaluable assistance of Deborah Williams, MHA, and Julie Fiskio, BA, and of Lindsay B. Renner, BA, Jessica Payne-Murphy, BA, Kathryn A. Griffiths, MA, and Susan L. Rose.
This study was supported by a research grant from the Aetna Quality Care Research Fund.
Conflict of interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harris, A.M., Orav, E.J., Bates, D.W. et al. Somatization Increases Disability Independent of Comorbidity. J GEN INTERN MED 24, 155–161 (2009). https://doi.org/10.1007/s11606-008-0845-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-008-0845-0